Edition:
United States

Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

1.89USD
4:00pm EDT
Change (% chg)

$-0.05 (-2.58%)
Prev Close
$1.94
Open
$1.92
Day's High
$1.92
Day's Low
$1.89
Volume
2,793
Avg. Vol
16,238
52-wk High
$3.50
52-wk Low
$1.20

Analyst Research
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - Acasti Pharma Inc (APO-V) 5:09am EDT Thomson Reuters Stock Report 11 25.00
Acasti Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 23 Sep 2016 Reuters Investment Profile 12 20.00
ACASTI PHARMA INC (ACST=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS 23 Sep 2016 Pechala's Reports 2 25.00
Wright Investors Service Comprehensive Report for Acasti Pharma Inc 15 Sep 2016 Wright Reports 62 75.00
Acasti Pharma Inc. (APO) - Financial Analysis Review 16 May 2016 GlobalData 40 300.00
Thomson Reuters Stock Report - Acasti Pharma Inc (APO-V) 10 May 2016 Thomson Reuters Stock Report 11 25.00
 
Name Age Since Current Position

Roderick Carter

2016 Executive Chairman of the Board

Jan D'Alvise

2016 President, Chief Executive Officer

Mario Paradis

2015 Chief Financial Officer

Pierre Lemieux

2010 Chief Operating Officer

Laurent Harvey

Vice President- Clinical and Non-Clinical Affairs